Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-15

Clinical Trial Update: Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial update for dociparstat in combination with standard chemotherapy in acute myeloid leukemia; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dociparstat (dociparstat)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: TERMINATED | Results posted: 2024-04-15